Literature DB >> 8664997

Long-term incidence of lower-extremity amputations in a diabetic population.

S E Moss1, R Klein, B E Klein.   

Abstract

OBJECTIVE: To describe the 10-year cumulative incidence of and risk factors for lower-extremity amputations in diabetics.
DESIGN: Cohort study.
SETTING: Primary care. PARTICIPANTS: Population-based sample (N = 879) of younger-onset diabetic persons (in whom diabetes was diagnosed before 30 years of age and who were taking insulin) and a stratified random sample (N = 956) of older-onset diabetic persons (diagnosis at or after 30 years of age) participating in baseline, 4-year, and 10-year examinations. MAIN OUTCOME MEASURE: Amputations of the lower extremities as reported by the participants.
RESULTS: The 10-year cumulative incidence of lower-extremity amputation was 5.4% in younger-onset and 7.3% in older-onset persons. Multivariate analyses were performed by logistic regression. In younger-onset persons, age (odds ratio [OR] for 10 years, 2.0; 95% confidence interval [CI], 1.5-2.8), history of ulcers (OR,4.8; 95% CI, 2.3-9.9), diastolic blood pressure (OR, 2.1 for 10 mm Hg; 95% CI, 1.5-3.0), glycosylated hemoglobin level (OR, 1.4 for 1%; 95% CI, 1.2-1.6), sex (OR, 5.2 for men; 95% CI, 2.2-12.3), and retinopathy (OR, 1.2 for 2 steps; 95% CI, 1.1-1.4) were significantly associated with incidence of lower-extremity amputation. In older-onset persons, history of ulcers (OR, 3.3; 95% CI, 1.6-6.8), glycosylated hemoglobin level (OR, 1.3 for 1%; 95% CI, 1.1-1.5), duration of diabetes (OR, 1.6 for 10 years; 95% CI, 1.1-2.5), sex (OR, 2.6 for men; 95% CI, 1.3-4.9), diastolic blood pressure (OR, 0.7 for 10 mm Hg; 95% CI, 0.5-1.0), and proteinuria (OR, 2.4; 95% CI, 1.0-5.7) were significantly associated with incidence of lower-extremity amputation.
CONCLUSION: These data show there are several risk factors for lower-extremity amputation with potential for modification and preventive strategies.

Entities:  

Mesh:

Year:  1996        PMID: 8664997     DOI: 10.1001/archfami.5.7.391

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  11 in total

Review 1.  Model-based evaluation of diabetic foot prevention strategies in Austria.

Authors:  Marion S Rauner; Kurt Heidenberger; Eva-Maria Pesendorfer
Journal:  Health Care Manag Sci       Date:  2005-11

Review 2.  Diabetes: foot ulcers and amputations.

Authors:  Dereck L Hunt
Journal:  BMJ Clin Evid       Date:  2011-08-26

Review 3.  Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis.

Authors:  A I Adler; S Erqou; T A S Lima; A H N Robinson
Journal:  Diabetologia       Date:  2010-02-03       Impact factor: 10.122

Review 4.  Diabetes: foot ulcers and amputations.

Authors:  Dereck Hunt
Journal:  BMJ Clin Evid       Date:  2009-01-12

5.  The relationship of regional hemoglobin A1c testing and amputation rate among patients with diabetes.

Authors:  Karina A Newhall; Kimon Bekelis; Bjoern D Suckow; Daniel J Gottlieb; Adrienne E Farber; Philip P Goodney; Jonathan S Skinner
Journal:  Vascular       Date:  2016-07-09       Impact factor: 1.285

Review 6.  Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.

Authors:  Kurt Neeser; Georg Lübben; Uwe Siebert; Wendelin Schramm
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

7.  Predicting development of proliferative diabetic retinopathy.

Authors:  Kristen Harris Nwanyanwu; Nidhi Talwar; Thomas W Gardner; James S Wrobel; William H Herman; Joshua D Stein
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

8.  A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol.

Authors:  Daria O'Reilly; Ron Linden; Ludwik Fedorko; Jean-Eric Tarride; Wilhelmine Giffening Jones; James M Bowen; Ron Goeree
Journal:  Trials       Date:  2011-03-07       Impact factor: 2.279

Review 9.  Growth factors for treating diabetic foot ulcers.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Susana Nicola; Daniel Simancas-Racines; Ludovic Reveiz; Patricio Oliva; Jorge Cedeño-Taborda
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

Review 10.  Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Yurong Zhang; Gang Hu; Zuyi Yuan; Liwei Chen
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.